Clinical Laserthermia Systems AB announced it has entered into an exclusive distribution agreement with MTEC Company ("MTEC") to market and sell the CLS TRANBERG® product portfolio in France. Since December 2023 the TRANBERG system is being used in the French national study IRMPROFT. Based on the growing interest for focal therapies in France, CLS is now entering into an exclusive distribution agreement with MTEC.

CLS and MTEC are now launching the TRANBERG system in France for Ultrasound image-guided focal laser ablation (FLA) of localized prostate cancer using temperature control. Next step in the market launch is participation in the national scientific BPH/Prostate meeting in Bordeaux, 23-24 May, where the TRANBERG system will be displayed by MTEC, with support from CLS. This meeting brings together key opinion leaders within prostate cancer field and will be an excellent platform for the broader market introduction in France.